Literature DB >> 20726066

Prostate cancer: Degarelix controls serum alkaline phosphatase better than leuprolide.

Nick Warde.   

Abstract

Entities:  

Year:  2010        PMID： 20726066     DOI： 10.1038/nrurol.2010.111

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study.

Authors:  Fritz H Schröder; Bertrand Tombal; Kurt Miller; Laurent Boccon-Gibod; Neal D Shore; E David Crawford; Judd Moul; Tine Kold Olesen; Bo-Eric Persson
Journal:  BJU Int       Date:  2009-11-13       Impact factor: 5.588
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.